top of page
Our Portfolio
Our portfolio reflects the scale and diversity of the broader healthcare venture capital market.
For over 13 years, we have created customized solutions for venture funds, corporate venture funds, limited partnership interests, operating companies, and individual shareholders.
NeuroPace was founded to design, develop, manufacture and market implantable devices for the treatment of neurological disorders with responsive stimulation.
Preventice Solutions focuses on mobile health solutions and remote monitoring services. It was acquired by Boston Scientific in 2021.
Acutus Medical is a dynamic arrhythmia care company leading the charge in the EP Revolution Ultra High Resolution Imaging and Mapping System. IPO in 2020, NASDAQ: AFIB
Torax Medical, Inc. develops and markets products designed to treat sphincter disorders utilizing its technology platform, Magnetic Sphincter Augmentation (MSA). It was acquired by Johnson & Johnson's Ethicon in 2017.
iRhythm is a digital healthcare company redefining the way cardiac arrhythmias are clinically diagnosed. IPO in 2016 (NASDAQ: IRTC).
SurgiQuest Inc. develops, manufactures and markets innovative access technologies for minimally invasive surgery. It was acquired by ConMed in 2016.
ClearCorrect is a clear aligner system used to straighten teeth as an alternative to traditional braces. It was acquired by Straumann Group in 2017.
Corventis is a pioneer in wearable, wireless technologies for cardiac disease. It was acquired by Medtronic in 2014.
TransMedics, Inc. is a medical device company founded to address the unmet need for more and better organs for transplantation. IPO in 2019 (NASDAQ: TMDX).
Pulsar Vascular Inc developed the PulseRider minimally invasive, self-expanding nitinol implant. It was acquired by Codman Neuro in 2016.
Veran's SPiN Thoracic Navigation System® is revolutionizing bronchoscopy and transforming the standard of care for early lung cancer diagnoses.
Endologix, Inc. is singularly focused on providing innovative, minimally invasive technologies for aortic disorders. IPO in 2018 (NASDAQ: ELGX).
NOVADAQ is a leading developer of fluorescence imaging technology. It was acquired by Stryker Corporation in 2017.
ViewRay, Inc. designs, manufactures, and markets the MRIdian® radiation therapy system. IPO in 2015 (NASDAQ: VRAY).
Advanced Surgical Concepts focuses on offering a high quality, service oriented environment for surgical procedures.
A global leader in interventional pulmonology, planning tools, and treatments for obstructive lung disease.
bottom of page